• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.开发和完善一项远程医疗干预措施,以管理乳腺癌患者的症状、减轻痛苦和提高辅助内分泌治疗的依从性。
J Clin Psychol Med Settings. 2021 Sep;28(3):603-618. doi: 10.1007/s10880-020-09750-4. Epub 2020 Nov 21.
2
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.一项针对症状管理、困扰和辅助内分泌治疗依从性的远程医疗干预:一项随机对照试验。
Cancer. 2022 Oct 1;128(19):3541-3551. doi: 10.1002/cncr.34409. Epub 2022 Aug 4.
3
The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.患者的声音:乳腺癌辅助内分泌治疗的依从性、症状与痛苦
Int J Behav Med. 2020 Dec;27(6):687-697. doi: 10.1007/s12529-020-09908-2.
4
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.支持乳腺癌女性辅助内分泌治疗依从性:使用多阶段优化策略指导的干预映射开发复杂行为干预。
BMC Health Serv Res. 2022 Aug 24;22(1):1081. doi: 10.1186/s12913-022-08243-4.
5
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.确定从行为干预中受益以提高辅助内分泌治疗依从性的患者亚组:一项随机对照试验。
Breast Cancer Res Treat. 2024 Apr;204(3):547-559. doi: 10.1007/s10549-023-07228-z. Epub 2024 Jan 17.
6
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).测试一种改善辅助内分泌治疗(AET)依从性的行为干预措施。
Contemp Clin Trials. 2019 Jan;76:120-131. doi: 10.1016/j.cct.2018.11.010. Epub 2018 Nov 22.
7
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer.早期激素受体阳性乳腺癌女性患者报告的症状和辅助内分泌治疗依从性的种族差异。
JAMA Netw Open. 2022 Aug 1;5(8):e2225485. doi: 10.1001/jamanetworkopen.2022.25485.
8
Study protocol for a randomised controlled feasibility trial of a virtual intervention (STRIDE) for symptom management, distress and adherence to adjuvant endocrine therapy after breast cancer.一项随机对照可行性试验研究方案:用于管理乳腺癌辅助内分泌治疗后症状、困扰和依从性的虚拟干预(STRIDE)。
BMJ Open. 2021 Jan 4;11(1):e041626. doi: 10.1136/bmjopen-2020-041626.
9
Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.影响乳腺癌治疗后女性接受辅助内分泌治疗依从性的因素:利用真实世界数据为从急性疾病管理向慢性疾病管理的转变提供信息。
Breast Cancer Res Treat. 2020 Aug;183(1):189-199. doi: 10.1007/s10549-020-05748-6. Epub 2020 Jun 26.
10
Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.乳腺癌辅助内分泌治疗的依从性:绝经后妇女症状归因的定性探讨。
Support Care Cancer. 2024 Apr 2;32(4):265. doi: 10.1007/s00520-024-08463-w.

引用本文的文献

1
Intervention-Related Changes in Coping Ability Drives Improvements in Mood and Quality of Life for Patients Taking Adjuvant Endocrine Therapy.应对能力的干预相关变化推动接受辅助内分泌治疗患者的情绪和生活质量改善。
Psychooncology. 2024 Dec;33(12):e70049. doi: 10.1002/pon.70049.
2
Effects of Adjuvant Endocrine Therapy-Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer.辅助内分泌治疗特异性认知对乳腺癌患者辅助内分泌治疗依从性的行为干预反应的影响。
JCO Oncol Pract. 2024 Dec;20(12):1645-1654. doi: 10.1200/OP.24.00316. Epub 2024 Aug 13.
3
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.确定从行为干预中受益以提高辅助内分泌治疗依从性的患者亚组:一项随机对照试验。
Breast Cancer Res Treat. 2024 Apr;204(3):547-559. doi: 10.1007/s10549-023-07228-z. Epub 2024 Jan 17.
4
Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer.管理症状困扰:乳腺癌辅助内分泌治疗患者的关键因素。
J Pain Symptom Manage. 2024 Jan;67(1):88-97. doi: 10.1016/j.jpainsymman.2023.10.001. Epub 2023 Oct 9.
5
Effectiveness of telemedicine-based psychosocial intervention for breast cancer patients: a systematic review and meta-analysis.基于远程医疗的乳腺癌患者心理社会干预的效果:系统评价和荟萃分析。
Support Care Cancer. 2023 Sep 28;31(10):595. doi: 10.1007/s00520-023-08052-3.
6
Marital status and perceived stress in men with advanced prostate cancer: A randomized-controlled trial of cognitive behavioral stress management.婚姻状况与晚期前列腺癌男性的感知压力:认知行为压力管理的随机对照试验。
J Psychosom Res. 2023 Apr;167:111198. doi: 10.1016/j.jpsychores.2023.111198. Epub 2023 Feb 16.
7
A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.一项针对症状管理、困扰和辅助内分泌治疗依从性的远程医疗干预:一项随机对照试验。
Cancer. 2022 Oct 1;128(19):3541-3551. doi: 10.1002/cncr.34409. Epub 2022 Aug 4.
8
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.简短放松训练与乳腺癌女性长期内分泌治疗依从性相关:一项随机对照试验的事后分析。
Breast Cancer Res Treat. 2021 Nov;190(1):79-88. doi: 10.1007/s10549-021-06361-x. Epub 2021 Aug 19.
9
Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study.为老年髓系肿瘤患者开发和改编移动医疗锻炼干预措施:一项定性研究。
J Geriatr Oncol. 2021 Jul;12(6):909-914. doi: 10.1016/j.jgo.2021.02.023. Epub 2021 Mar 4.

本文引用的文献

1
Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.与乳腺癌幸存者内分泌治疗不依从相关的因素。
Psychooncology. 2020 Apr;29(4):647-654. doi: 10.1002/pon.5289. Epub 2020 Feb 11.
2
Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.年轻女性乳腺癌辅助内分泌治疗中的不依从行为。
Cancer. 2019 Sep 15;125(18):3266-3274. doi: 10.1002/cncr.32192. Epub 2019 May 23.
3
Nonpharmacological Interventions for Cancer-Related Fatigue: A Systematic Review and Bayesian Network Meta-Analysis.非药物干预癌症相关疲劳:系统评价和贝叶斯网络荟萃分析。
Worldviews Evid Based Nurs. 2019 Apr;16(2):102-110. doi: 10.1111/wvn.12352. Epub 2019 Mar 28.
4
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.激素受体阳性乳腺癌女性的辅助内分泌治疗:美国临床肿瘤学会临床实践指南重点更新
J Oncol Pract. 2019 Feb;15(2):106-107. doi: 10.1200/JOP.18.00617. Epub 2018 Dec 5.
5
Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis.促进乳腺癌幸存者坚持内分泌治疗的干预措施:一项荟萃分析。
Psychooncology. 2019 Feb;28(2):255-263. doi: 10.1002/pon.4959. Epub 2018 Dec 28.
6
A systematic review of interventions to improve adherence to endocrine therapy.系统评价改善内分泌治疗依从性的干预措施。
Breast Cancer Res Treat. 2019 Feb;173(3):499-510. doi: 10.1007/s10549-018-5012-7. Epub 2018 Nov 1.
7
Evidence for telehealth group-based treatment: A systematic review.远程医疗团体治疗的证据:系统评价。
J Telemed Telecare. 2019 Jul;25(6):327-342. doi: 10.1177/1357633X18775855. Epub 2018 May 22.
8
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.在综合性医疗保健系统中,个人和临床社会支持与激素受体阳性乳腺癌患者对辅助内分泌治疗的依从性之间的关系。
Breast Cancer Res Treat. 2018 Aug;170(3):623-631. doi: 10.1007/s10549-018-4774-2. Epub 2018 Apr 18.
9
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?改善乳腺癌幸存者内分泌治疗依从性的干预措施:有哪些证据?
J Cancer Surviv. 2018 Jun;12(3):348-356. doi: 10.1007/s11764-017-0674-4. Epub 2018 Feb 2.
10
Prospective investigation of social support, coping, and depressive symptoms: A model of adherence to endocrine therapy among women with breast cancer.前瞻性调查社会支持、应对方式和抑郁症状:乳腺癌女性内分泌治疗依从性模型。
J Consult Clin Psychol. 2018 Mar;86(3):242-253. doi: 10.1037/ccp0000272. Epub 2017 Dec 21.

开发和完善一项远程医疗干预措施,以管理乳腺癌患者的症状、减轻痛苦和提高辅助内分泌治疗的依从性。

Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.

机构信息

Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Yawkey, Suite 10B, Boston, MA, 02114, USA.

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

出版信息

J Clin Psychol Med Settings. 2021 Sep;28(3):603-618. doi: 10.1007/s10880-020-09750-4. Epub 2020 Nov 21.

DOI:10.1007/s10880-020-09750-4
PMID:33219901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8137723/
Abstract

Adjuvant endocrine therapy (AET) prevents recurrence after early stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established; however, interventions, thus, far have failed to produce meaningful changes in adherence and have generally not followed guiding principles of psychosocial intervention development. The purpose of this paper is to describe the iterative development, using the National Institutes of Health Stage Model for Behavioral Intervention Development, of an evidence-based, patient-centered, telehealth intervention to enhance adherence, improve symptom management, and reduce distress for patients taking AET after breast cancer, with a focus on (1) a small open pilot study which informed modifications and refinement of the intervention based on quantitative and qualitative patient feedback about feasibility and acceptability and (2) the underlying theoretical and empirical rationale for each component of the finalized intervention. Clinical implications and directions for future research are discussed.

摘要

辅助内分泌治疗(AET)可预防早期激素敏感型乳腺癌的复发;然而,AET 的依从性并不理想,有效的干预措施严重缺乏。人们已经充分了解了依从性的障碍;然而,迄今为止的干预措施并没有在依从性上产生有意义的变化,并且通常没有遵循心理社会干预发展的指导原则。本文的目的是描述使用美国国立卫生研究院行为干预发展阶段模型对循证、以患者为中心的远程医疗干预措施进行的迭代开发,以增强接受乳腺癌后 AET 治疗的患者的依从性,改善症状管理,并减轻其痛苦,重点是:(1) 一项小型开放试点研究,根据患者对可行性和可接受性的定量和定性反馈,对干预措施进行了修改和完善;(2) 最终干预措施的每个组成部分的基础理论和实证依据。讨论了临床意义和未来研究方向。